Kura Oncology's total assets for Q2 2025 were $682.42M, a decrease of -8.25% from the previous quarter. KURA total liabilities were $376.94M for the fiscal quarter, a -0.64% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.